Current Review on Environmental Factors and Screening of Cancer

International Journal of Pharmacy and Biomedical Engineering

© 2022 by SSRG - IJPBE Journal

Volume 9 Issue 3

Year of Publication : 2022

Authors : Sri Naga Varun Mutte, Ijaz Sheik, Gali Yamini Srinivas, Ashok Thulluru

10.14445/23942576/IJPBE-V9I3P101

How to Cite?

Sri Naga Varun Mutte, Ijaz Sheik, Gali Yamini Srinivas, Ashok Thulluru, "Current Review on Environmental Factors and Screening of Cancer," SSRG International Journal of Pharmacy and Biomedical Engineering, vol. 9,  no. 3, pp. 1-11, 2022. Crossref, https://doi.org/10.14445/23942576/IJPBE-V9I3P101

Abstract:

Cancer alludes to over 277 distinct malignancies in its broadest sense. The pathogenesis of these cancers has uncovered various cancer stages in which gene mutations will play a key role. Abnormal multiplication of cells occurs due to these mutations in the genes. Environmental factors are thought to be responsible for 70-90 percent of all carcinomas. A tissue with a large number of stem cells is considered a sign of developing carcinoma in that particular tissue. The characterization of tumors is done by obtaining stem cell-like properties, which shows evidence that a stem cell-like population endures and proliferates tumors. Finding people who appear healthy in a community, have a disease in its earliest stages, or are more likely to get a condition is known as screening in the healthcare industry. An early diagnosis of an illness, which can subsequently be efficiently treated at an early stage, results in a decreased diseasespecific or overall fatality. This is the aim of a screening test. In this, the effects of different environmental exposures that may impair functions of stem cells related to carcinogenesis. Several cancer screening methods were identified in the mid of the 20th century. In this article, we have discussed the effectiveness and evaluation of the screening of cancer programs in different countries. This article also established the estimated number of deaths and new cases observed worldwide in 2018. In this review, we have also established the molecular perspectives of cancer. The economic constraints related to the screening problems are also discussed.

Keywords:

Pathogenesis, Environmental factors, Diagnosis, Screening, Molecular perspectives, Economic constraints.

References:

[1] Meacham C and Morrison S, "Tumour heterogeneity and cancer cell plasticity". Nature, vol. 501, pp. 328-37. 2013. Crossref, https://doi.org/10.1038/nature12624 
[2] Fisher R, Pusztai L and Swanton C, “Cancer heterogeneity: implications for targeted therapeutics". British journal of cancer, vol. 108 pp. 479-85, 2013. Crossref, https://doi.org/10.1038/bjc.2012.581
[3] Siegel RL, Miller KD and Jemal A, “Cancer statistics, 2016,” CA: a cancer journal for clinicians, vol. 66, no. 1, pp. 7-30, 2016, Crossref, https://doi.org/https://doi.org/10.3322/caac.21332
[4] Schottenfeld, David and Joseph F, “Cancer Epidemiology and Prevention,” 3rd edn, Oxford Academic, 2006.
[5] Yoo KY and Shin HR, “Cancer epidemiology and prevention,” Korean Journal of Epidemiology, vol. 25, pp. 1-15, 2003.
[6] Aizawa K, Liu C, Tang S, Veeramachaneni S, Hu KQ, Smith DE and Wang XD, “Tobacco Carcinogen Induces Both Lung Cancer and Non-Alcoholic Steatohepatitis and Hepatocellular Carcinomas in Ferrets Which can be Attenuated By Lycopene Supplementation,” International Journal of Cancer, vol. 139, no. 5, pp. 1171-81, 2016. Crossref, https://doi.org/https://doi.org/10.1002/ijc.30161
[7] Poon SL, McPherson JR, Tan P, Teh BT and Rozen SG, “Mutation Signatures of Carcinogen Exposure: Genome-Wide Detection and New Opportunities for Cancer Prevention,” Genome Medicine, vol. 6, no. 24, 2014. Crossref, https://doi.org/10.1186/gm541
[8] Trafialek J and Kolanowski W, "Dietary Exposure To Meat-Related Carcinogenic Substances: Is There A Way To Estimate The Risk?" International Journal of Food Sciences and Nutrition, vol. 65, no. 6, pp. 774-80, 2014. Crossref, https://doi.org/10.3109/09637486.2014.917146
[9] Cumberbatch MG, Cox A, Teare D and Catto JW, “Contemporary Occupational Carcinogen Exposure and Bladder Cancer: a Systematic Review and Meta-Analysis,” JAMA Oncology, vol. 1, no. 1, pp. 1282-90, 2015. Crossref, https://doi.org/10.1001/jamaoncol.2015.3209
[10] Antwi SO, Eckert EC, Sabaque CV, Leof ER, Hawthorne KM, Bamlet WR, Chaffee KG, Oberg AL and Petersen GM, “Exposure To Environmental Chemicals and Heavy Metals, and Risk of Pancreatic Cancer,” Cancer Causes & Control, vol. 26, no. 11, pp. 1583-91, 2015. Crossref, https://doi.org/10.1007/s10552-015-0652-y
[11] Parkin DM, “The Global Health Burden of Infection-Associated Cancers in the Year 2002". International Journal of Cancer, vol. 118, no. 12, pp. 3030-44, 2006. Crossref, https://doi.org/10.1002/ijc.21731
[12] Seto M, Honma K and Nakagawa M, “Diversity of Genome Profiles in Malignant Lymphoma,” Cancer Science, vol. 101, no. 3, pp. 573-8, 2010. Crossref, https://doi.org/10.1111/j.1349-7006.2009.01452.x
[13] Cigudosa JC, Parsa NZ, Louie DC, Filippa DA, Jhanwar SC, Johansson B, Mitelman F and Chaganti RS, “Cytogenetic Analysis of 363 Consecutively Ascertained Diffuse Large B-cell Lymphomas". Genes, Chromosomes and Cancer, vol. 25, no. 2, pp. 123- 33,1999.
[14] Matlashewski G, Lamb P, Pim D, Peacock J, Crawford L, Benchimol S. "Isolation And Characterization Of A Human P53 Cdna Clone: Expression Of The Human P53 Gene". The EMBO Journal, vol. 3, no. 13, pp. 3257–3262,, 1984. Crossref, https://doi.org/10.1002/j.1460-2075.1984.tb02287.x
[15] Wei Q, Li L and Chen D, DNA Repair, Genetic Instability, and Cancer,” World Scientific, pp. 376, 2007. Crossref, https://doi.org/10.1142/6228
[16] Wood RD, Mitchell M, Sgouros J and Lindahl T. “Human DNA Repair Genes,” Science, vol. 291, pp. 1284-9, 2001. Crossref, https://doi.org/10.1126/science.1056154
[17] Joensuu H and Dimitrijevic S, “Tyrosine Kinase Inhibitor Imatinib (STIS71) as an Anti-Cancer Agent for Solid Tumours,” Annals of Medicine, vol, 33, pp. 451-455, 2001. Crossref, https://doi.org/10.3109/07853890109002093
[18] King CR, Kraus MH and Aaronson SA, “Amplification of a Novel V-Erbb-Related Gene in a Human Mammary Carcinoma,” Science, vol. 229, pp. 974-7, 1985. Crossref, https://doi.org/10.1126/science.2992089
[19] Heinrich MC, Blanke CD, Druker BJ and Corless CL. "Inhibition of KIT Tyrosine Kinase Activity: a Novel Molecular Approach to the Treatment of Kit-Positive Malignancies,” Journal of Clinical Oncology, vol. 20, pp. 1692-703, 2002. Crossref, https://doi.org/10.1200/JCO.2002.20.6.1692
[20] Thomas RK, Baker AC, DeBiasi RM, et al, “High-Throughput Oncogene Mutation Profiling in Human Cancer,” Nature Genetics, vol. 39, no. 3, pp. 347-51, 2007. Crossref, https://doi.org/10.1038/ng1975
[21] May P and May E, “Twenty Years of P53 Research: Structural and Functional Aspects of the P53 Protein,” Oncogene, vol. 18, no. 53, pp. 7621, 1999. Crossref, https://doi.org/10.1038/sj.onc.1203285
[22] McBride O, Merry D, Givol D. "The Gene For Human P53 Cellular Tumor Antigen Is Located On Chromosome 17 Short Arm (17p13),” Proceedings of the National Academy of Sciences, vol. 83, no. 1, pp. 130-4, 1986. Crossref, https://doi.org/10.1073/pnas.83.1.130
[23] Isobe M, Emanuel B, Givol D, Oren M and Croce CM, “Localization of Gene for Human P53 Tumour Antigen to Band 17p13,” Nature, vol. 320, pp. 84-85, 1986. Crossref, https://doi.org/10.1038/320084a0
[24] Miller C and Koeffler H, “P53 Mutations in Human Cancer,” Leukemia, vol. 7, no. 2, pp. S18-21, 1993.
[25] Koshland Jr DE, “Molecule of the Year,” Science, vol. 258, 1992. Crossref, https://doi.org/10.1126/science.1470903
[26] Muller PA and Vousden KH, “Mutant P53 in Cancer: New Functions and Therapeutic Opportunities,” Cancer Cell, vol. 25, no. 3, pp. 304-17, 2014. Crossref, https://doi.org/10.1016/j.ccr.2014.01.021
[27] Selivanova G, “P53: Fighting Cancer,” Current Cancer Drug Targets, vol. 4, no. 5, pp. 385-402, 2004. Crossref, https://doi.org/10.2174/1568009043332934 
[28] Goelz SE, Vogelstein B, Hamilton SR and Feinberg AP, “Hypo Methylation of DNA from Benign and Malignant Human Colon Neoplasms,” Science, vol. 228, no. 4696, pp. 187-91, 1985. Crossref, https://doi.org/10.1126/science.2579435
[29] Kanai Y, Hirohashi S, “Alterations of DNA Methylation Associated with Abnormalities of DNA Methyltransferases in Human Cancers During Transition from a Precancerous to a Malignant State,” Carcinogenesis, vol. 28, no. 12, pp. 2434-42, 2007. Crossref, https://doi.org/10.1093/carcin/bgm206 [30] Wilson AS, Power BE and Molloy PL, “DNA Hypomethylation and Human Diseases,” Biochimicaet Biophysica Acta, vol. 1775, no. 1, pp. 138-62, 2007. Crossref, https://doi.org/10.1016/j.bbcan.2006.08.007
[31] Esteller M, “Epigenetic Gene Silencing in Cancer: the Dna Hypermethylome,” Human Molecular Genetics, vol. 16, no. 1, pp. R50- R9, 2007. Crossref, https://doi.org/10.1093/hmg/ddm018
[32] Li M, Chen W-d, Papadopoulos N, et al, “Sensitive Digital Quantification of DNA Methylation in Clinical Samples,” Nature Biotechnology, vol. 27, no. 9, pp. 858-63, 2009. Crossref, https://doi.org/10.1038/nbt.1559
[33] Doi A, Park I-H, Wen B, et al. "Differential methylation of tissue-and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts". Nature genetics. 2009; 41: 1350-3.
[34] Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C. "Cancer genetics of epigenetic genes". Human molecular genetics. 2007; 16: R28-R49.
[35] Dalgliesh GL, Furge K, Greenman C, et al, “Systematic Sequencing of Renal Carcinoma Reveals Inactivation of Histone Modifying Genes,” Nature, vol. 463, pp. 360-3, 2010. Crossref, https://doi.org/10.1038/nature08672
[36] Chang. Q, Chen. B, Thakur. C, Lu. Y and Chen. F, “Arsenic-Induced Sub-Lethal Stress Reprograms Human Bronchial Epithelial Cells to Cd61 Cancer Stem Cells,” Oncotarget, vol. 5, no. 5, pp. 1290–1303, 2014. Crossref, https://doi.org/10.18632/oncotarget.1789
[37] Person. R. J, Ngalame. N. N. O, Makia. N. L, Bell. M. W, Waalkes. M. P and Tokar. E. J, “Chronic Inorganic Arsenic Exposure in Vitro Induces a Cancer Cell Phenotype in Human Peripheral Lung Epithelial Cells,” Toxicology and Applied Pharmacology, vol. 286, no. 1, pp. 36-43, 2015. Crossref, https://doi.org/10.1016/j.taap.2015.03.014
[38] Tokar. E. J, Qu. W, Liu, J, Liu. W, Webber. M. M, Phang. J. M and Waalkes. M. P, “Arsenic-Specific Stem Cell Selection During Malignant Transformation,” Journal of the National Cancer Institute, vol. 102, no. 9, pp. 638-649, 2010. Crossref, https://doi.org/10.1093/jnci/djq093
[39] Ooki A, Begum A, Marchionni L, VandenBussche C. J, Mao S, Kates M and Hoque M. O, “Arsenic Promotes the COX2/PGE2- SOX2 Axis to Increase the Malignant Stemness Properties of Urothelial Cells,” International Journal of Cancer, vol. 143, no. 1, pp. 113–126, 2018. Crossref, https://doi.org/10.1002/ijc.31290
[40] Xu Y, Tokar E. J and Waalkes M. P, “Arsenic-Induced Cancer Cell Phenotype in Human Breast Epithelia is Estrogen Receptor-Independent but Involves Aromatase Activation,” Archives of Toxicology, vol. 88, no. 2, pp. 263–274, 2014. Crossref, https://doi.org/10.1007/s00204-013-1131-4
[41] Ngalame N. N. O, Makia N. L, Waalkes M. P and Tokar E. J, “Mitigation of Arsenic-Induced Acquired Cancer Phenotype in Prostate Cancer Stem Cells By miR-143 Restoration,” Toxicology and Applied Pharmacology, vol. 312, pp. 11-18, 2016. Crossref, https://doi.org/10.1016/j.taap.2015.12.013
[42] Ngalame N. N. O, Luz A. L, Makia N and Tokar E. J, “Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype,” Toxicological Sciences, vol. 165, no. 1, pp. 40–49, 2018. Crossref, https://doi.org/10.1093/toxsci/kfy176
[43] Waalkes and M. P, “Cadmium Carcinogenesis,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 533, no. 1-2, pp. 107-20, 2003. Crossref, https://doi.org/10.1016/j.mrfmmm.2003.07.011
[44] Qu W, Tokar E. J, Kim A. J, Bell M. W and Waalkes M. P, “Chronic Cadmium Exposure in Vitro Causes Acquisition of Multiple Tumor Cell Characteristics in Human Pancreatic Epithelial Cells,” Environmental Health Perspectives, vol. 120, no. 9, pp. 1265– 1271, 2012. Crossref, https://doi.org/10.1289/ehp.1205082
[45] Gallagher C. M, Chen J. J and Kovach J. S, “Environmental Cadmium and Breast Cancer Risk,” Aging, vol. 2, no. 11, pp. 804–814, 2010. Crossref, https://doi.org/10.18632/aging.100226
[46] Van Maele-Fabry G, Lombaert N and Lison D, “Dietary Exposure to Cadmium and Risk of Breast Cancer in Postmenopausal Women: a Systematic Review and Meta-Analysis,” Environment International, vol. 86, pp. 1-13, 2016. Crossref, https://doi.org/10.1016/j.envint.2015.10.003
[47] Johnson M. D, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G and Martin M. B, “Cadmium Mimics the in Vivo Effects of Estrogen in the Uterus and Mammary Gland,” Nature Medicine, vol. 9, no. 8, pp. 1081–1084, 2003. Crossref, https://doi.org/10.1038/nm902
[48] Parodi D. A, Evans C, Williams J, Greenfield M, Cyrus K. C, Martin M. B and Martin M. B, “Alteration of Mammary Gland Development and Gene Expression by in Utero Exposure to Cadmium,” International Journal of Molecular Sciences, vol. 18, no. 9, pp. 1939, 2017. Crossref, https://doi.org/10.3390/ijms18091939
[49] Kenney N. J, Smith, G. H, Lawrence E, Barrett J. C and Salomon D. S, “Identification of Stem Cell Units in the Terminal end Bud and Duct of the Mouse Mammary Gland,” Journal of Biomedicine and Biotechnology, vol. 1, no. 3, pp. 133-143, 2001. Sri Naga Varun Mutte et al. / IJPBE, 9(3), 1-11, 2022 9
[50] Gibb H J, Lees P S J, Pinsky P. F and Rooney B. C, “Lung Cancer Among Workers in Chromium Chemical Production,” American Journal of Industrial Medicine,vol. 38, no. 2, pp. 115-26, 2000. Crossref, https://doi.org/10.1002/1097- 0274(200008)38:23.0.co;2-y
[51] He J, Qian X, Carpenter R, Xu Q, Wang L, Qi Y and Jiang B. H, “Repression of MIR-143 Mediates Cr (VI)-Induced Tumor Angiogenesis via IGF-IR/IRS1/ERK/IL-8 Pathway,” Toxicological Sciences, vol. 134, no. 1, pp. 26-38, 2013. Crossref, https://doi.org/10.1093/toxsci/kft101
[52] Wang Z, Wu J, Humphries B, Kondo K, Jiang Y, Shi X and Yang C, “Upregulation of Histone-Lysine Methyltransferases Plays a Causal Role in Hexavalent Chromium Induced Cancer Stem Cell-Like Property and Cell Transformation,” Toxicology and Applied Pharmacology, vol. 342, pp. 22-30, 2018. Crossref, https://doi.org/10.1016/j.taap.2018.01.022
[53] Dai J, Ji Y, Wang W, Kim D, Fai L. Y, Wang L and Zhang Z, “Loss of Fructose-1,6- Bisphosphatase Induces Glycolysis and Promotes Apoptosis Resistance of Cancer Stemlike Cells: an Important Role in Hexavalent Chromium-Induced Carcinogenesis,” Toxicology and Applied Pharmacology, vol. 331, pp. 164–173, 2017. Crossref, https://doi.org/10.1016/j.taap.2017.06.014
[54] Li W J, Yang C. L, Chow K. C and Kuo T. W, “Hexavalent Chromium Induces Expression of Mesenchymal and Stem Cell Markers in Renal Epithelial Cells,” Molecular Carcinogenesis, vol. 55, no. 2, pp. 182-92, 2016. Crossref, https://doi.org/10.1002/mc.22268
[55] Proctor R. N, “Tobacco and the Global Lung Cancer Epidemic,” Nature Reviews Cancer, vol. 1, no. 1, pp. 82-6, 2001. Crossref, https://doi.org/10.1038/35094091
[56] Torre L, Bray F, Siegel R. L, Ferlay J, Lortet-Tieulent J and Jernal A “Global Cancer Statistics,” CA Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87-108, 2015. Crossref, https://doi.org/10.3322/caac.20107
[57] DeMarini D. M, “Genotoxicity of Tobacco Smoke and Tobacco Smoke Condensate: a Review,” Mutation Research, Reviews in Mutation Research, vol. 567, no. 2–3, pp. 447–474, 2004. Crossref, https://doi.org/10.1016/j.mrrev.2004.02.001
[58] Xie C, Zhu J, Wang X, Chen J, Geng S, Wu J and Li X, “Tobacco Smoke-Induced Hepatic Cancer Stem Cell-Like Properties Through IL-33/p38 Pathway,” Journal of Experimental & Clinical Cancer Research. 2019; 38(1):39. Crossref, https://doi.org/10.1186/s13046-019-1052-z
[59] Hilakivi-Clarke L, “Maternal Exposure to Diethylstilbestrol During Pregnancy and Increased Breast Cancer Risk in Daughters,” Breast Cancer Research, vol. 16, no. 2, pp. 208, 2014. Crossref, https://doi.org/10.1186/bcr3649
[60] Herbst A. L, Ulfelder H, and Poskanzer D. C, “Adenocarcinoma of the Vagina. Association of Maternal Stilbestrol Therapy with Tumor Appearance In Young Women,” The New England Journal of Medicine, vol. 284, no. 15, pp. 878-881, 1971. Crossref, https://doi.org/10.1056/NEJM197104222841604
[61] Troisi R, Hatch E. E, Titus-Ernstoff L, Hyer M, Palmer J. R, Robboy S. J and Hoover R. N, “Cancer Risk in Women Prenatally Exposed to Diethylstilbestrol,” International Journal of Cancer, vol. 121, no. 2, pp. 356-60, 2007. Crossref, https://doi.org/10.1002/ijc.22631
[62] Hsu P. Y, Deatherage D. E, Rodriguez B. A. T, Liyanarachchi S, Weng Y. I, Zuo T and Huang T. H. M, “Xenoestrogen-Induced Epigenetic Repression of Microrna-9-3 in Breast Epithelial Cells,” Cancer Research, vol. 69, no. 14, pp. 5936–5945, 2009. Crossref, https://doi.org/10.1158/0008-5472.CAN-08-4914
[63] Calafat A. M, Ye X, Wong L Y, Reidy J. A and Needham L. L, “Exposure of the U.S. Population to Bisphenol a and 4- Tertiary - Octylphenol: 2003–2004,” Environmental Health Perspectives. 2008; 116(1): 39–44.
[64] Hindman A. R, Mo, X. M, Helber H. L, Kovalchin C. E, Ravichandran N, Murphy A. R and Burd C. J, "Varying Susceptibility of the Female Mammary Gland to in Utero Windows of BPA Exposure,” Endocrinology, vol. 158, no. 10, pp. 3435–3447, 2017. Crossref, https://doi.org/10.1210/en.2017-00116
[65] Kitamura S, Suzuki T, Sanoh S, Kohta, R, Jinno N, Sugihara, K and Ohta S, “Comparative Study of the Endocrine-Disrupting Activity of Bisphenol a and 19 Related Compounds,” Toxicological Sciences, vol. 84, no. 2, pp. 249–259, 2005. Crossref, https://doi.org/10.1093/toxsci/kfi074
[66] Ullah A, Pirzada M, Jahan S,Ullah H and Khan M. J, “Bisphenol A Analogues Bisphenol B, Bisphenol F, and Bisphenol S Induce Oxidative Stress, Disrupt Daily Sperm Production, and Damage Dna in Rat Spermatozoa: a Comparative in Vitro And in Vivo Study,” Toxicology and Industrial Health, vol. 35, no. 4, pp. 294-303, 2019. Crossref, https://doi.org/10.1177/0748233719831528
[67] Weiler K and Ramakrishnan S, “Bisphenol F Causes Disruption of Gonadotropinreleasing Hormone Neural Development in Zebrafish via an Estrogenic Mechanism,” NeuroToxicology, vol. 71, pp. 31-38, 2019. Crossref, https://doi.org/10.1016/j.neuro.2018.12.001
[68] Barr, L, Metaxas G, Harbach C. A. J, Savoy L. A and Darbre P. D. "Measurement of Paraben Concentrations in Human Breast Tissue at Serial Locations Across the Breast From Axilla to Sternum,” Journal of Applied Toxicology, vol. 32, no. 3, pp. 219-232, 2012. Crossref, https://doi.org/10.1002/jat.1786
[69] Antonia M Calafat, Xiaoyun Ye, Lee-Yang Wong, Amber M Bishop and Larry L Needham, “Urinary Concentrations of Four Parabens in the U.S. Population: NHANES 2005–2006,” Environmental Health Perspectives, vol. 118, no. 5, pp. 679–685, 2010. Crossref, https://doi.org/10.1289/ehp.0901560
[70] Hu P, Chen X, Whitener R. J, Boder E. T, Jones J. O, Porollo A and Zhao L, “Effects of Parabens on Adipocyte Differentiation,” Toxicological Sciences, vol. 131, no. 1, pp. 56–70, 2013. Crossref, https://doi.org/10.1093/toxsci/kfs262 
[71] Hu P, Overby H, Heal E, Wang S, Chen J, Shen C and Zhao L, “Methylparaben and Butylparaben Alter Multipotent Mesenchymal Stem Cell Fates Towards Adipocyte Lineage". Toxicology and Applied Pharmacology, vol. 329, pp. 48–57, 2017. Crossref, https://doi.org/10.1016/j.taap.2017.05.019
[72] Esper R. M, Dame M, McClintock S, Holt P. R, Dannenberg A. J, Wicha M. S and Brenner D. E, “Leptin and Adiponectin Modulate the Self-Renewal of Normal Human Breast Epithelial Stem Cells,” Cancer Prevention Research (Philadelphia, Pa.),vol. 8, no. 12, pp. 1174–1183, 2015. Crossref, https://doi.org/10.1158/1940-6207.CAPR-14-0334
[73] Hill E. M, Esper R. M, Simon B. R, Aslam M. N, Jiang Y, Dame M. K and Brenner D. E, “Dietary Polyunsaturated Fatty Acids Modulate the Adipose Secretome to Influence Mammary Stem Cell Self-Renewal,” Journal of Nutritional Biochemistry, vol. 71, pp. 45-53, 2019.
[74] Sonthithai P, Suriyo T, Thiantanawat A, Watcharasit P, Ruchirawat M and Satayavivad J, “Perfluorinated Chemicals, PFOS and PFOA, Enhance the Estrogenic Effects of 17β-Estradiol in T47D Human Breast Cancer Cells,” Journal of Applied Toxicology, vol. 36, no. 6, pp. 790–801, 2016. Crossref, https://doi.org/10.1002/jat.3210
[75] Mostafalou, S and Abdollahi M, “Pesticides And Human Chronic Diseases: Evidences, Mechanisms, And Perspectives,” Toxicology and Applied Pharmacology, vol. 268, no. 2, pp. 157-77, 2013. Crossref, https://doi.org/10.1016/j.taap.2013.01.025
[76] Eldakroory S, Morsi El D, Abdel-Rahman R, Roshdy S, Gouida M and Khashaba E, “Correlation Between Toxic Organochlorine Pesticides and Breast Cancer,” Human & Experimental Toxicology, vol. 36, no. 12, pp. 1326–1334, 2017. Crossref, https://doi.org/10.1177/0960327116685887
[77] International Agency for Research on Cancer (2015)“DDT, lindane and 2,4-D,” IARC Working Group. Lyon. (2–9 June, IARC MonogrEvalCarcinog Risks Hum).
[78] Sapbamrer R, Prapamontol T, Prakobvitayakit O, Vaneesorn Y, Mangklabruks A and Hock, B, “Placental Transfer of DDT In Mother-Infant Pairs from Northern Thailand,” Journal of Environmental Science and Health - Part B Pesticides, Food Contaminants, and Agricultural Wastes, vol. 43, no. 6, pp. 484–489, 2008.
[79] Strong A, Shi Z, Strong M, Miller D, Rusch D, Buechlein A et al, “Effects of the Endocrine-Disrupting Chemical DDT on SelfRenewal and Differentiation of Human Mesenchymal Stem Cells,” Environmental Health Perspectives, vol. 123, no. 1, pp. 42-48, 2015. Crossref, https://doi.org/10.1289/ehp.1408188
[80] Aamir M, Khan S and Li G, “Dietary Exposure to HCH and DDT Congeners and Their Associated Cancer Risk Based on Pakistani Food Consumption,” Environmental Science and Pollution Research, vol. 25, no. 9, pp. 8465-8474, 2018. Crossref, https://doi.org/10.1007/s11356-017-1129-1
[81] Gillison, M. L, Broutian T, Pickard R. K. L, Tong Z. Y, Xiao W, Kahle L and Chaturvedi A. K, “Prevalence of Oral HPV Infection in the United States, 2009-2010,” JAMA: The Journal of the American Medical Association, vol. 307, no. 7, pp. 693–703, 2012. Crossref, https://doi.org/10.1001/jama.2012.101
[82] Pullos A. N, Castilho R. M and Squarize C. H, “HPV Infection of the Head and Neck Region and its Stem Cells,” Journal of Dental Research, vol. 94, no. 11, pp. 1532–1543, 2015. Crossref, https://doi.org/10.1177/0022034515605456
[83] Zhang M, Kumar B, Piao L, Xie X, Schmitt A, Arradaza N, Pan Q, “Elevated Intrinsic Cancer Stem Cell Population in Human Papillomavirus-Associated Head and Neck Squamous Cell Carcinoma,” Cancer, vol. 120, no. 7, pp. 992–1001, 2014. Crossref, https://doi.org/10.1002/cncr.28538
[84] Tang A. L, Owen J. H, Hauff S. J, Park J. J, Papagerakis S, Bradford C. R and Prince M. E, “Head and Neck Cancer Stem Cells". Otolaryngology-Head and Neck Surgery, vol. 149, no. 2, pp. 252–260, 2013. Crossref, https://doi.org/10.1177/0194599813486599
[85] Tyagi A, Vishnoi K, Mahata S, Verma G, Srivastava Y, Masaldan, S and Das B. C, “Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stem Ness and Self-Renewal Through Upregulation of HES1,” Clinical Cancer Research, vol. 22, no. 16, pp. 4170–4184, 2016. Crossref, https://doi.org/10.1158/1078-0432.CCR-15-2574
[86] Xiong L, Wu F, Wu Q, Xu L, Cheung OK, Kang W, Mok MT, Szeto LLM, Lun CY, Lung RW, Zhang J, Yu KH, Lee SD, Huang G, Wang CM, Liu J, Yu Z, Yu DY, Chou JL, Huang WH, Feng B, Cheung YS, Lai PB, Tan P, Wong N, Chan MW, Huang TH, Yip KY, Cheng AS and To KF, “Aberrant Enhancer Hypomethylation Contributes to Hepatic Carcinogenesis Through Global Transcriptional Reprogramming,” Nature Communications, vol. 10, no. 1, pp. 335, 2019. Crossref, https://doi.org/10.1038/s41467- 018-08245-z
[87] Hsia CC, Evarts RP, Nakatsukasa H, Marsden ER and Thorgeirsson SS, “Occurrence of Oval-Type Cells in Hepatitis B Virus Associated Human Hepatocarcinogenesis,” Hepatology, vol. 16, no. 6, pp. 1327–1333, 1992. Crossref, https://doi.org/10.1002/hep.1840160604
[88] Erker L and Grompe M, “Signaling Networks in Hepatic Oval Cell Activation,” Stem Cell Research, vol. 1, no. 2, pp. 90–102, 2008. Crossref, https://doi.org/10.1016/j.scr.2008.01.002
[89] Libbrecht L, Desmet V, Van Damme B and Roskams T, “Deep intralobular extension of human hepatic "Progenitor Cells" Correlates with Parenchymal Inflammation in Chronic Viral Hepatitis: Can "Progenitor Cells" Migrate?,” Journal of Pathology, vol. 192, no. 3, pp. 373-8, 2000. Crossref, https://doi.org/10.1002/1096-9896(2000)9999:99993.0.CO;2-5
[90] Prentice RL, Kato H, Yoshimoto K and Mason M, “Radiation Exposure and Thyroid Cancer Incidence Among Hiroshima and Nagasaki Residents,” Natl Cancer Inst Monograph, vol. 62, pp. 207-12, 1982.
[91] Land CE, Tokunaga M, Koyama K, Soda M, Preston DL, Nishimori I and Tokuoka S, “Incidence of Female Breast Cancer Among Atomic Bomb Survivors, Hiroshima and Nagasaki, 1950-1990,” Radiation Research, vol. 160, no. 6, pp. 707–717, 2003. Crossref, https://doi.org/10.1667/rr3082
[92] Ron E, Preston DL, Kishikawa M, Kobuke T, Iseki M, Tokuoka S, Tokunaga M and Mabuchi K, “Skin Tumor Risk Among Atomic-Bomb Survivors In Japan,” Cancer Causes & Control, vol. 9, no. 4, pp. 393-401, 1998. Crossref, https://doi.org/10.1023/a:1008867617415
[93] Douple E, Mabuchi K, Cullings H, Preston D, Kodama K, Shimizu Y et al, “Long-Term Radiation-Related Health Effects In A Unique Human Population: Lessons Learned From The Atomic Bomb Survivors Of Hiroshima And Nagasaki,” Disaster Medicine and Public Health Preparedness, vol. 5, no. S1, pp. S122-S133, 2011. Crossref, https://doi.org/10.1001/dmp.2011.21
[94] Notara M, Refaian N, Braun G, Steven P, Bock F and Cursiefen C, “Short-Term Uvb-Irradiation Leads to Putative Limbal Stem Cell Damage and Niche Cell-Mediated Upregulation of Macrophage Recruiting Cytokines,” Stem Cell Research, vol. 15, no. 3, pp. 643–654, 2015. Crossref, https://doi.org/10.1016/j.scr.2015.10.008
[95] Wong DY, Ranganath T and Kasko AM, “Low-Dose, Long-Wave UV Light Does Not Affect Gene Expression of Human Mesenchymal Stem Cells,” PLoS One, vol. 10, no. 9, pp. 1–21, 2015. Crossref, https://doi.org/10.1371/journal.pone.0139307
[96] Thong T, Forté C, Hill E and Colacino J, “Environmental Exposures, Stem Cells, and Cancer,” Pharmacology & Therapeutics, vol. 204. pp. 107398, 2019. Crossref, https://doi.org/10.1016/j.pharmthera.2019.107398
[97] Morrison A, Screening in chronic disease. New York: Oxford University Press, vol. 4, pp. 565–566, 1993. Crossref, https://doi.org/10.1007/BF00052433
[98] Smith R and Oeffinger K, “The Importance of Cancer Screening,” Medical Clinics of North America, vol. 104, no. 6, pp. 919-938. 2020. Crossref, https://doi.org/10.1016/j.mcna.2020.08.008
[99] MihirChandarana, Kapila Shrestha and Rishikesh Parmeshwar, “Principles of Cancer Screening,” Surgery (Oxford), vol. 39, no. 4, pp. 221-227, 2021. Crossref, https://doi.org/10.1016/j.mpsur.2021.01.016